Cervilenz Boosts Series A to $8.35M

4 years ago

Cleveland-based Cervilenz has added to its Series A round, closing the round with $8.35 million. The company, backed by investors including Arboretum Ventures and Chrysalis Ventures, plans to use the funding to continue commercialization of its medical devices for women. The device is designed to predict the risk of preterm birth in pregnant women.

Continue

Slideshow: 15 Largest U.S.-based Venture Funds Raised in Q3

By Lawrence Aragon — 4 years ago

Q3 certainly wasn’t a pretty quarter for venture fundraising. In fact, it was downright ugly, with just $1.72 billion raised by 52 U.S.-based venture funds, the smallest amount raised since Q3 2003, according to the National Venture Capital Association and Thomson Reuters (publisher of peHUB). In contrast, 49 U.S.-based VC funds raised nearly $2.9 billion in […]

Continue

MyHealthDIRECT Seals $4M Series B

5 years ago

MyHealthDIRECT, a web-based system that allows patients to schedule healthcare appointments, has closed its Series B investment round with $4 million. Ann Arbor, Mich.-based Arboretum Ventures and Louisville, Kentucky-based Chrysalis Ventures provided the funding, which will be used to expand sales, client services and technical resources, the company said.

Continue

NxThera Adds $12.6M Series B

5 years ago

NxThera Inc., a St. Paul, Minn.-based medical devices company, has added $12.6 million in Series B financing. American Medical Systems Inc. led the round, and was joined by existing investors Arboretum Ventures, Aberdare Ventures and GDN Holdings. NxThera is developing medical technologies to treat a variety of endourology conditions.

Continue

Arboretum Raises $70.2M Toward New $125M Fund

By Mark Boslet — 5 years ago

Early stage health care investor Arboretum Ventures has raised $70.2 million toward a new $125 million fund, representing a significant expansion of the firm. The partnership, based in Ann Arbor, Mich., released the news in a filing with the Securities and Exchange Commission on Wednesday. The 8-year-old firm is now investing its second fund and […]

Continue

PathCentral Raises $10 Million In Series B Financing

By Luisa Beltran — 5 years ago

PathCentral said Tuesday that it has raised $10 million in Series B financing. Okapi Venture Capital, Arboretum Ventures, and Baird Venture Partners co-led the round. Irvine, Calif.-based PathCentral is an anatomic pathology services company. Okapi Venture Capital is a seed and early stage life sciences and information technology investor. Arboretum Ventures, of Ann Arbor, Mich., is an early stage VC firm that focuses on healthcare services. Baird Venture Partners is the VC fund of Baird Private Equity.

Continue

George Dunbar Joins Arboretum Ventures

By PEHub Administrator — 6 years ago

George Dunbar has joined Ann Arbor, Mich.-based Arboretum Ventures as a venture partner. Last month he stepped down as president and CEO of stem cell company Aastrom Biosciences Inc. (Nasdaq: ASTM). Prior CEO jobs have been with Quantum Dot (bought by Invitrogen) and Epic Therapeutics (Baxter). www.arboretumvc.com

Continue

CerviLenz Raises $4 Million

By PEHub Administrator — 7 years ago

CerviLenz Inc., a Cleveland-based maker of disposable devices used to predict the risk of preterm birth in pregnant women, has raised $4 million in first-round funding. Arboretum Ventures led the round, and was joined by Chrysalis Ventures. PRESS RELEASE CerviLenz Inc., a manufacturer and distributor of a disposable device used to predict the risk of preterm […]

Continue

VC-Backed Healthmedia Sells To J&J

By PEHub Administrator — 7 years ago

New Brunswick, NJ, (October 27, 2008) – As an initial step in the creation of a wellness and prevention business platform, Johnson & Johnson announced today it has acquired HealthMedia, Inc., a privately held company located in Ann Arbor, Michigan, that creates web-based behavior change interventions. Terms of the transaction were not disclosed. HealthMedia combines […]

Continue